[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100616027":3},{"organization":4,"armGroups":7,"interventions":30,"overallOfficials":43,"centralContacts":47,"locations":53,"responsibleParty":235,"collaborators":35,"id":237,"slug":238,"hasResults":239,"nctId":240,"briefTitle":241,"officialTitle":242,"acronym":35,"eligibilityCriteria":243,"healthyVolunteers":244,"sex":245,"minAge":246,"maxAge":247,"enrollmentInfo":248,"targetDuration":35,"studyType":251,"phases":252,"briefSummary":254,"conditions":255,"keywords":35,"overallStatus":56,"whyStopped":35,"lastUpdateSubmitDate":257,"lastUpdatePostDateStruct":258,"startDateStruct":261,"completionDateStruct":263,"leadSponsor":265,"locationsCount":266},{"fullName":5,"class":6},"Merck Sharp & Dohme LLC","INDUSTRY",[8,14,19,25],{"label":9,"type":10,"description":11,"interventionNames":12},"V118C (Stage 1)","EXPERIMENTAL","Participants will receive a single 0.5 mL intramuscular (IM) injection of V118C administered at 12 to 15 months of age.",[13],"Biological: V118C (Stage 1)",{"label":15,"type":10,"description":16,"interventionNames":17},"V118C (Stage 2)","Participants will receive a single 0.5 mL IM injection of V118C administered at 2,4,6, and 12 months of age.",[18],"Biological: V118C (Stage 2)",{"label":20,"type":21,"description":22,"interventionNames":23},"PCV20 (Stage 1)","ACTIVE_COMPARATOR","Participants will receive a single 0.5 mL IM injection of PCV20 administered at 12 to 15 months of age.",[24],"Biological: PCV20 (Stage 1)",{"label":26,"type":21,"description":27,"interventionNames":28},"PCV20 (Stage 2)","Participants will receive a single 0.5 mL IM injection of PCV20 administered at 2,4,6, and 12 months of age.",[29],"Biological: PCV20 (Stage 2)",[31,36,38,41],{"type":32,"name":9,"description":33,"armGroupLabels":34,"otherNames":35},"BIOLOGICAL","IM administration of V118C",[9],null,{"type":32,"name":15,"description":33,"armGroupLabels":37,"otherNames":35},[15],{"type":32,"name":20,"description":39,"armGroupLabels":40,"otherNames":35},"IM administration of PCV20",[20],{"type":32,"name":26,"description":39,"armGroupLabels":42,"otherNames":35},[26],[44],{"name":45,"affiliation":5,"role":46},"Medical Director","STUDY_DIRECTOR",[48],{"name":49,"role":50,"phone":51,"phoneExt":35,"email":52},"Toll Free Number","CONTACT","1-888-577-8839","Trialsites@msd.com",[54,72,85,97,110,123,136,149,162,175,186,199,210,222],{"facility":55,"status":56,"city":57,"state":58,"zip":59,"country":60,"countryCode":61,"cosmosGeoPoint":62,"geoPoint":67,"contacts":68},"Madera Family Medical Group ( Site 1004)","RECRUITING","Madera","California","93637","United States","US",{"type":63,"coordinates":64},"Point",[65,66],-120.06072,36.96134,{"lat":66,"lon":65},[69],{"name":70,"role":50,"phone":71,"phoneExt":35,"email":35},"Study Coordinator","559-673-3000",{"facility":73,"status":56,"city":74,"state":75,"zip":76,"country":60,"countryCode":61,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Acevedo Clinical Research Associates ( Site 1029)","Miami","Florida","33142",{"type":63,"coordinates":78},[79,80],-80.19366,25.77427,{"lat":80,"lon":79},[83],{"name":70,"role":50,"phone":84,"phoneExt":35,"email":35},"305-649-8871",{"facility":86,"status":56,"city":87,"state":75,"zip":88,"country":60,"countryCode":61,"cosmosGeoPoint":89,"geoPoint":93,"contacts":94},"University of South Florida-Department of Pediatrics ( Site 1002)","Tampa","33606",{"type":63,"coordinates":90},[91,92],-82.45843,27.94752,{"lat":92,"lon":91},[95],{"name":70,"role":50,"phone":96,"phoneExt":35,"email":35},"813-821-8039",{"facility":98,"status":56,"city":99,"state":100,"zip":101,"country":60,"countryCode":61,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Cotton O'Neil Research Center ( Site 1039)","Topeka","Kansas","66604",{"type":63,"coordinates":103},[104,105],-95.67804,39.04833,{"lat":105,"lon":104},[108],{"name":70,"role":50,"phone":109,"phoneExt":35,"email":35},"785-354-6000",{"facility":111,"status":56,"city":112,"state":113,"zip":114,"country":60,"countryCode":61,"cosmosGeoPoint":115,"geoPoint":119,"contacts":120},"University of Louisville, Norton Children's Research Institute ( Site 1005)","Louisville","Kentucky","40202",{"type":63,"coordinates":116},[117,118],-85.75941,38.25424,{"lat":118,"lon":117},[121],{"name":70,"role":50,"phone":122,"phoneExt":35,"email":35},"502-629-5820",{"facility":124,"status":56,"city":125,"state":126,"zip":127,"country":60,"countryCode":61,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"The Pediatric Center ( Site 1025)","Columbia","Maryland","21045",{"type":63,"coordinates":129},[130,131],-76.83942,39.24038,{"lat":131,"lon":130},[134],{"name":70,"role":50,"phone":135,"phoneExt":35,"email":35},"443-721-7224",{"facility":137,"status":56,"city":138,"state":139,"zip":140,"country":60,"countryCode":61,"cosmosGeoPoint":141,"geoPoint":145,"contacts":146},"Saint Louis University Center for Vaccine Development ( Site 1031)","St Louis","Missouri","63104",{"type":63,"coordinates":142},[143,144],-90.19789,38.62727,{"lat":144,"lon":143},[147],{"name":70,"role":50,"phone":148,"phoneExt":35,"email":35},"314-977-6333",{"facility":150,"status":56,"city":151,"state":152,"zip":153,"country":60,"countryCode":61,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"Child Health Care Associates ( Site 1035)","East Syracuse","New York","13057",{"type":63,"coordinates":155},[156,157],-76.07853,43.06534,{"lat":157,"lon":156},[160],{"name":70,"role":50,"phone":161,"phoneExt":35,"email":35},"315-652-8800",{"facility":163,"status":56,"city":164,"state":165,"zip":166,"country":60,"countryCode":61,"cosmosGeoPoint":167,"geoPoint":171,"contacts":172},"Tribe Clinical Research, LLC-Pediatrics ( Site 1008)","Greenville","South Carolina","29607",{"type":63,"coordinates":168},[169,170],-82.39401,34.85262,{"lat":170,"lon":169},[173],{"name":70,"role":50,"phone":174,"phoneExt":35,"email":35},"864-334-0141",{"facility":176,"status":56,"city":177,"state":165,"zip":178,"country":60,"countryCode":61,"cosmosGeoPoint":179,"geoPoint":183,"contacts":184},"Tribe Clinical Research - Spartanburg ( Site 1001)","Spartanburg","29301",{"type":63,"coordinates":180},[181,182],-81.93205,34.94957,{"lat":182,"lon":181},[185],{"name":70,"role":50,"phone":174,"phoneExt":35,"email":35},{"facility":187,"status":56,"city":188,"state":189,"zip":190,"country":60,"countryCode":61,"cosmosGeoPoint":191,"geoPoint":195,"contacts":196},"Epic Medical Research - Carrollton ( Site 1038)","Carrollton","Texas","75006",{"type":63,"coordinates":192},[193,194],-96.89028,32.95373,{"lat":194,"lon":193},[197],{"name":70,"role":50,"phone":198,"phoneExt":35,"email":35},"972-777-6956",{"facility":200,"status":56,"city":201,"state":189,"zip":202,"country":60,"countryCode":61,"cosmosGeoPoint":203,"geoPoint":207,"contacts":208},"Epic Medical Research- Garland ( Site 1017)","Garland","75043",{"type":63,"coordinates":204},[205,206],-96.63888,32.91262,{"lat":206,"lon":205},[209],{"name":70,"role":50,"phone":198,"phoneExt":35,"email":35},{"facility":211,"status":56,"city":212,"state":189,"zip":213,"country":60,"countryCode":61,"cosmosGeoPoint":214,"geoPoint":218,"contacts":219},"University of Texas Medical Branch ( Site 1020)","League City","77573",{"type":63,"coordinates":215},[216,217],-95.09493,29.50745,{"lat":217,"lon":216},[220],{"name":70,"role":50,"phone":221,"phoneExt":35,"email":35},"832-340-2313",{"facility":223,"status":56,"city":224,"state":225,"zip":226,"country":60,"countryCode":61,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Pediatric Research of Charlottesville, LLC ( Site 1012)","Charlottesville","Virginia","22902",{"type":63,"coordinates":228},[229,230],-78.47668,38.02931,{"lat":230,"lon":229},[233],{"name":70,"role":50,"phone":234,"phoneExt":35,"email":35},"434-872-9384",{"type":236,"investigatorFullName":35,"investigatorTitle":35,"investigatorAffiliation":35,"oldNameTitle":35,"oldOrganization":35},"SPONSOR","100616027","phase-1-a-clinical-study-of-novel-pneumococcal-vaccine-v118c-in-children-v118c-002-100616027",false,"NCT07300267","A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)","A Phase 1, Randomized, Double-Blind, Active Comparator Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Novel Pneumococcal Vaccine in Children","Inclusion Criteria:\n\nThe main inclusion criteria include but are not limited to the following:\n\nStage 1:\n\n* Is previously vaccinated with 3 routine infant doses of Pneumococcal 20-valent conjugate vaccine (PCV20)\n* Is 12 through 15 months of age\n\nStage 2:\n\n\\- Is approximately 2 months of age\n\nBoth Stages:\n\n* Was born at full term (gestational age greater than or equal to 37 weeks)\n\nExclusion Criteria:\n\nThe main exclusion criteria include but are not limited to the following:\n\nStage 1:\n\n\\- Has received a PCV dose at 10 months of age and older\n\nStage 2:\n\n* Has received prior administration of any pneumococcal vaccine\n\nBoth stages:\n\n* Has a history of invasive pneumococcal disease (IPD)\n* Has a known hypersensitivity to any component of V118C or PCV20 including diphtheria toxoid",true,"ALL","2 Months","15 Months",{"count":249,"type":250},210,"ESTIMATED","INTERVENTIONAL",[253],"PHASE1","Researchers are looking for new vaccines to prevent pneumococcal disease, which is any infection in the lungs or other parts of the body that is caused by a type of bacteria called Streptococcus pneumoniae. V118C is a new vaccine designed to help prevent disease from Streptococcus pneumoniae bacteria.\n\nThis study will look at V118C in toddlers and infants. The goal of the study is to learn how safe V118C is for children and how well they tolerate it.",[256],"Pneumococcal Infection","2026-04-15",{"date":259,"type":260},"2026-04-17","ACTUAL",{"date":262,"type":260},"2026-01-13",{"date":264,"type":250},"2029-05-25",{"name":5,"class":6},14]